Merck & Co. has elected Robert M. Davis, current CEO and President of Merck, to serve as Chairman of the Board, effective December 1, 2022. He will succeed Kenneth C. Frazier, current Executive Chairman of Merck, a role he began in July 2021 following his retirement from a decade-long tenure as Merck’s President and CEO.

Davis became Merck’s President in April 2021 and was named Merck’s CEO and a member of its board in July 2021.

Frazier is retiring from his role as Executive Chairman, effective November 30, 2022 after a long-tenured career at Merck that began in 1992. Frazier led the company for 10 years as President and CEO from 2011 through 2021. He has served as a Merck Director since January 2011 and as Chairman of its Board of Directors since December 2011.

Source: Merck & Co.